Showing 49-60 of 368 results

Advance Subscription Agreements vs. Convertible Loan Notes

The pros and cons of Advance Subscription Agreements and Convertible Loan Notes
14 October 2022

European Commission’s consultation on compulsory licensing of patents: an overview

What does the recent European Commission consultation mean for pharmaceutical manufacturers IP rights?
14 October 2022

Press release

Burges Salmon advises on sale of a majority stake in C.P. Hart & Sons

The firm has acted for the shareholders of C.P. Hart & Sons on the sale of a majority stake in the business to the Wolseley Group

12 October 2022

Publication

The responsibilities and duties of a company director

This guide provides directors with a general overview of the key duties and obligations of the role.
12 October 2022

Key differences between UK and US venture capital transactions

UK start-ups continue to be attractive investment opportunities for US VC funds, highlighting the importance of understanding the jurisdictional differences
10 October 2022

Directors’ Duties under the Supreme Court’s Spotlight

In BTI 2014 LLC v Sequana SA & Ors [2022] the Supreme Court considered the duty owed by directors to creditors during times of financial difficulty
07 October 2022

Press release

Burges Salmon shortlisted in two categories at British Legal Awards 2022

The firm has been nominated for ‘M&A Team of the Year (Medium Deal - Less than £1bn)’ and ‘Property Team of the Year’
06 October 2022

Press release

Burges Salmon advises biotech company Nodus Oncology on launch

The firm’s Corporate Finance team has advised Nodus, founded by Cumulus Oncology and in partnership with the Lead Discovery Center

08 September 2022

Press release

Burges Salmon advises Albert Health on landmark seed investment

The digital health platform has received a $1 million investment led by Sabanci Ventures

26 July 2022

The Changing Regulatory Landscape of Medical Devices - What can we expect?

We explore the proposed changes published in the UK Government’s response to the MHRA’s consultation on the regulatory framework governing medical devices in the UK
25 July 2022

Press release

Burges Salmon advises Atrato Onsite on Hylton Plantation Solar Farm acquisition

Firm advises Atrato Onsite Energy on £10.6m acquisition of Hylton Plantation Solar Farm Limited
20 July 2022

Press release

Burges Salmon advises Cytomos Limited on £1.6m funding from trio of investors

Cytomos, an Edinburgh-based life science company, has secured funding to progress its novel cell analysis platform
12 July 2022

The Burges Salmon blog

Subscribe to news and insight

Events and webinars

Keep up to date with the latest legal developments. Attend an upcoming webinar or virtual event.
View all events